首页> 外文期刊>Journal of Medicinal Chemistry >Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.
【24h】

Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.

机译:Nociceptin(1-13)-NH(2)的Phe(4)残基的结构活性研究:Nociceptin / orphanin FQ受体的高效激动剂的鉴定。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A total of 32 compounds was prepared to investigate the functional role of Phe(4) in NC(1-13)-NH(2), the minimal sequence maintaining the same activity as the natural peptide nociceptin. These compounds could be divided into three series in which Phe(4) was replaced with residues that would (i) alter aromaticity or side chain length, (ii) introduce steric constraint, and (iii) modify the phenyl ring. Compounds were tested for biological activity as (a) inhibitors of the electrically stimulated contraction of the mouse vas deferens; (b) competitors of the binding of [(3)H]-NC-NH(2) to mouse brain membranes; and (c) inhibitors of forskolin-stimulated cAMP accumulation in CHO cells expressing the recombinant human OP(4) receptor. Results indicate that all compounds of the first and second series were inactive or very weak with the exception of [N(CH(3))Phe(4)]NC(1-13)-NH(2), which was only 3-fold less potent than NC(1-13)-NH(2). Compounds of the third series showed higher, equal, or lower potencies than NC(1-13)-NH(2). In particular, [(pF)Phe(4)]NC(1-13)-NH(2) (pF) and [(pNO(2))Phe(4)]NC(1-13)-NH(2) (pNO(2)) were more active than NC(1-13)-NH(2) by a factor of 5. In the mVD, these compounds showed the following order of potency: (pF) = (pNO(2)) > or = (pCN) > (pCl) > (pBr) > (pI) = (pCF(3)) = (pOCH(3)) > (pCH(3)) > (pNH(2)) = (pOH). (oF) and especially (mF) maintained high potencies but were less active than (pF). Similar orders of potency were observed in binding competition and cAMP accumulation studies. There was a strong (r(2) > or = 0.66) correlation between data observed in these assays. Biological activity data of compounds of the third series were plotted against some Hansch parameters that are currently used to quantify physicochemical features of the substituents. In the three biological assays agonist potency/affinity positively correlates with the electron withdrawal properties of the groups in the p-position of Phe(4) and inversely with their size.
机译:总共准备了32种化合物以研究Phe(4)在NC(1-13)-NH(2)中的功能作用,最小序列保持与天然肽伤害感受素相同的活性。这些化合物可分为三个系列,其中Phe(4)被残基取代,这些残基会(i)改变芳香性或侧链长度,(ii)引入空间约束,并且(iii)修饰苯环。测试化合物的生物活性,作为(a)小鼠输精管电刺激收缩的抑制剂; (b)[(3)H] -NC-NH(2)与小鼠脑膜结合的竞争者; (c)在表达重组人OP(4)受体的CHO细胞中forskolin刺激的cAMP积累的抑制剂。结果表明,除了[N(CH(3))Phe(4)] NC(1-13)-NH(2)之外,第一和第二系列的所有化合物均无活性或非常弱。折叠强度比NC(1-13)-NH(2)小。第三系列的化合物显示比NC(1-13)-NH(2)更高,相等或更低的效力。特别是[[pF)Phe(4)] NC(1-13)-NH(2)(pF)和[[pNO(2))Phe(4)] NC(1-13)-NH(2) (pNO(2))比NC(1-13)-NH(2)的活性高5倍。在mVD中,这些化合物显示出以下效力顺序:(pF)=(pNO(2)) >或=(pCN)>(pCl)>(pBr)>(pI)=(pCF(3))=(pOCH(3))>(pCH(3))>(pNH(2))=(pOH) 。 (oF)尤其是(mF)保持高效能,但活性却不及(pF)。在结合竞争和cAMP积累研究中观察到了相似的效力水平。在这些试验中观察到的数据之间存在很强的相关性(r(2)>或= 0.66)。针对当前用于定量取代基的理化特征的一些汉施参数,绘制了第三组化合物的生物活性数据。在这三种生物学测定中,激动剂的效价/亲和力与Phe(4)对位的基团的电子撤出特性成正比,与它们的大小成反比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号